CLOV vs WLYB · rev $1.37B vs P/E 15, rev $1.68B
Clover Health Investments Corp (CLOV) versus John Wiley & Sons B (WLYB) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
John Wiley & Sons B (WLYB) is a publishing company listed on NYSE.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported WLYB revenue for 2025-04-30 was $1.68B. Net income was $84.2M. Revenue was down 10.4% from 2024-04-30 to 2025-04-30. WLYB currently screens at market cap $2.26B and trailing P/E 15.4.
CLOV currently screens at market cap $1.55B. WLYB currently screens at market cap $2.26B and trailing P/E 15.4.
Not investment advice. Open the CLOV and WLYB stock pages for the full models.
Not investment advice.